The Pharmacogene Variation (PharmVar) Consortium , a central repository for pharmacogene (PGx) variation that focuses on haplotype structure...

The GWAS analysis on platelet reactivity and cardiovascular outcome for clopidogrel, the third paper by the   International Clopidogrel Pha...

The PharmVar GeneFocus: CYP2C19 paper, the second of the GeneFocus series, has just been published by Clinical Pharmacology & Therapeu...

The Centers for Medicare and Medicaid Services (CMS) have posted a FUTURE Local Coverage Determination (LCD) for MolDX: Pharmacogenomics...

After 20 years of NIH funding, the Pharmacogenomics Research Network (PGRN) is becoming an independent scientific society on July 1, 2020. T...

We are pleased to announce that Dr. Stuart Scott will be joining Stanford University as a Professor in the Department of Pathology effectiv...

PharmVar has announced the introduction of   DPYD   to its database.  DYPD   is the rate limiting enzyme involved in the catabolism of fluo...